By neutralizing FN1 or inhibiting integrin receptors, the invasive capacity of pancreatic cancer cells was significantly reduced (Figures 4F, G, 5M, N), with combined inhibition further decreasing invasiveness (Figures 5M, N). The gene discussed is FN1; the disease is familial pancreatic carcinoma.